Authors: BERGMAN J PARONIS CA

Citation: J. Bergman et Ca. Paronis, BACK TO THE FUTURE - COMMENTARY ON RODGERS, ANIMAL-MODELS OF ANXIETY,WHERE NEXT, Behavioural pharmacology, 8(6-7), 1997, pp. 502-504

Authors: PARONIS CA WOODS JH

Citation: Ca. Paronis et Jh. Woods, VENTILATION IN MORPHINE-MAINTAINED RHESUS-MONKEYS .1. EFFECTS OF NALTREXONE AND ABSTINENCE-ASSOCIATED WITHDRAWAL, The Journal of pharmacology and experimental therapeutics, 282(1), 1997, pp. 348-354

Authors: PARONIS CA WOODS JH

Citation: Ca. Paronis et Jh. Woods, VENTILATION IN MORPHINE-MAINTAINED RHESUS-MONKEYS .2. TOLERANCE TO THE ANTINOCICEPTIVE BUT NOT THE VENTILATORY EFFECTS OF MORPHINE, The Journal of pharmacology and experimental therapeutics, 282(1), 1997, pp. 355-362

Authors: PARONIS CA WOODS JH

Citation: Ca. Paronis et Jh. Woods, CLOCINNAMOX DOSE-DEPENDENTLY ANTAGONIZES MORPHINE-ANALGESIA AND [H-3]DAMGO BINDING IN RATS, European journal of pharmacology, 337(1), 1997, pp. 27-34

Authors: PARONIS CA HOLTZMAN SG

Citation: Ca. Paronis et Sg. Holtzman, SENSITIZATION AND TOLERANCE TO THE DISCRIMINATIVE STIMULUS EFFECTS OFMU-OPIOID AGONISTS, Psychopharmacology, 114(4), 1994, pp. 601-610

Authors: PARONIS CA WADDELL AB HOLTZMAN SG

Citation: Ca. Paronis et al., NALTREXONE IN-VIVO PROTECTS MU-RECEPTORS FROM INACTIVATION BY BETA-FUNALTREXAMINE, BUT NOT KAPPA-RECEPTORS FROM INACTIVATION BY NOR-BINALTORPHIMINE, Pharmacology, biochemistry and behavior, 46(4), 1993, pp. 813-817